A Lung Adenocarcinoma with a STRN-ALK Rearrangement Was Poorly Responsive to Alectinib Treatment

被引：0
|
作者：
Iida, Y. [1 ]
Nakanishi, Y. [2 ]
Takahashi, N. [1 ]
Nishimaki, H. [2 ]
Nishizawa, T. [1 ]
Nakagawa, Y. [1 ]
Shimizu, T. [1 ]
Gon, Y. [1 ]
Masuda, S. [2 ]
Hashimoto, S. [1 ]
机构：
[1] Nihon Univ, Sch Med, Dept Internal Med, Div Resp Med, Tokyo, Japan
[2] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Oncol Pathol, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
non-small cell lung cancer; Resistance; STRN/ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.03-009
引用
收藏
页码：S1953 / S1953
页数：1
相关论文
共 50 条
  • [21] Transformation of ALK rearrangement-positive adenocarcinoma to small-cell lung cancer in association with acquired resistance to alectinib
    Takegawa, N.
    Hayashi, H.
    Iizuka, N.
    Takahama, T.
    Ueda, H.
    Tanaka, K.
    Takeda, M.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2016, 27 (05) : 953 - 955
  • [22] ALK Rearrangement Adenocarcinoma with Histological Transformation to Squamous Cell Carcinoma Resistant to Alectinib and Ceritinib
    Kaiho, Taisuke
    Nakajima, Takahiro
    Iwasawa, Shunichiro
    Yonemori, Yoko
    Yoshino, Ichiro
    ONCOTARGETS AND THERAPY, 2020, 13 : 1557 - 1560
  • [23] Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement
    Caliez, J.
    Monnet, I.
    Pujals, A.
    Rousseau-Bussac, G.
    Jabot, L.
    Boudjemaa, A.
    Leroy, K.
    Chouaid, C.
    REVUE DES MALADIES RESPIRATOIRES, 2017, 34 (05) : 576 - 580
  • [24] Alectinib rescue therapy in advanced ALK rearranged lung adenocarcinoma: a case report
    Cesaro, Cristiano
    Caterino, Umberto
    Perrotta, Fabio
    Masi, Umberto
    Cotroneo, Alessandra
    Cianci, Roberta
    Zamparelli, Enzo
    Cesaro, Flavio
    Amore, Dario
    Rocco, Danilo
    MONALDI ARCHIVES FOR CHEST DISEASE, 2023, 93 (03)
  • [25] NCOA1-ALK: a novel ALK rearrangement in one lung adenocarcinoma patient responding to crizotinib treatment
    Cao, Qi
    Liu, Zhiguang
    Huang, Yanhua
    Qi, Chuang
    Yin, Xiaowei
    ONCOTARGETS AND THERAPY, 2019, 12 : 1071 - 1074
  • [26] Primary resistance to alectinib in a patient with STRN-ALK-positive non-small cell lung cancer: A case report
    Sun, Kunyan
    Nie, Ligong
    Nong, Lin
    Cheng, Yuan
    THORACIC CANCER, 2021, 12 (12) : 1927 - 1930
  • [27] Lung adenocarcinoma with EGFR 19Del and an ALK rearrangement benefits from alectinib instead of an EGFR-TKI: A case report
    Wang, Hongbiao
    Zhu, Sujuan
    Li, Zhifeng
    Qi, Xiaofang
    Zhang, Liwen
    Ke, Leiyu
    Lin, Yingcheng
    MEDICINE, 2022, 101 (35) : E30316
  • [28] AlectinibTransformation of ALK rearrangement-positive adenocarcinoma to small-cell lung cancer in association with acquired resistance to alectinib : case report
    Reactions Weekly, 2016, 1607 (1) : 35 - 35
  • [29] A COMPARISON OF FISH AND IMMUNOHISTOCHEMISTRY IN THE DETECTION OF ALK REARRANGEMENT IN LUNG ADENOCARCINOMA
    Le Quesne, John
    Maurya, Manisha
    De Castro, David Gonzalez
    Popat, Sanjay
    Wotherspoon, Andrew
    Nicholson, Andrew
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1085 - S1086
  • [30] THE CASE REPORT OF LUNG ADENOCARCINOMA THYROID METASTASIS OF ALK REARRANGEMENT
    Tian, Tian
    Hong, Fu
    Zhang, Zhihong
    Qian, Liting
    ACTA MEDICA MEDITERRANEA, 2020, 36 (03): : 1307 - 1310
12345